Quantbot Technologies’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Quantbot Technologies’s Portfolio SYRS Stock Details SYRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-130	Closed	-$1K	–	2218
2022 Q1	$1K	Hold	130	–	–	﹤0.01%	1587
2021 Q4	$4K	Buy	+130	New	+$5.26K	﹤0.01%	1398
2021 Q3	–	Sell	-130	Closed	-$7K	–	1998
2021 Q2	$7K	Buy	130 +90	+225%	+$5.33K	﹤0.01%	1342
2021 Q1	$2K	Buy	+40	New	+$4.16K	﹤0.01%	1339
2020 Q4	–	Sell	-20	Closed	-$1K	–	1759
2020 Q3	$1K	Buy	+20	New	+$2.27K	﹤0.01%	1249

Other funds holding SYRS

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Quantbot Technologies's SYRS Position: Q2 2022 in Review

Quantbot Technologies sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q2 2022, closing a stake of 130 shares — an estimated $1K sold.

Quantbot Technologies first reported a position in SYRS in Q3 2020 and held it in 5 quarters. The position peaked at $7K in Q2 2021. 67 funds tracked by Wall St. Rank hold SYRS as of Q2 2022.

Quantbot Technologies reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Quantbot Technologies sold 130 Syros Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $1K.
Quantbot Technologies first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 5 quarters.
Quantbot Technologies's Syros Pharmaceuticals, Inc. Common Stock position peaked at $7K in Q2 2021.
67 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Quantbot Technologies's 13F filing for Q2 2022, filed 9 Aug 2022.